Capsaicin topical - Maruishi Pharmaceutical

Drug Profile

Capsaicin topical - Maruishi Pharmaceutical

Alternative Names: MR3H3

Latest Information Update: 09 Aug 2011

Price : $50

At a glance

  • Originator Maruishi
  • Developer Maruishi Pharmaceutical
  • Class Antipruritics; Catechols; Local anaesthetics; Monounsaturated fatty acids; Non-opioid analgesics; Polyunsaturated alkamides; Small molecules
  • Mechanism of Action Nociceptin receptor antagonists; TRPV1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Postherpetic neuralgia

Most Recent Events

  • 27 May 2005 Three preclinical studies have been added to the Pain pharmacodynamics section ,)
  • 12 May 2005 Phase-II clinical trials in Postherpetic neuralgia in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top